Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BMSN is OTCQB and a regularly reporting company which it has in its favor. It is not a "pink sheet". See http://www.otcmarkets.com/stock/BMSN/quote
Thanks for posting this link. For BMSN to qualify on a 30 day over a penny price, we need positive PR by Monday, the March 31st previously given company time frame deadline for news.
If BMSN can continue to qualify, it will help them. If Koos knows about this and FDA news is bad, then BMSN will be given the boot and REGEN will become the penny stock. Everything depends on whether or not good news is forthcoming.
http://mobile.reuters.com/article/idUSL1N0MN13N20140326?irpc=932
Done.
The silence is disconcerting. BMSN was supposed to file FDA response with experiments safety timeline ending in early March, so the filing could have all been prepared ahead of time except for safety aspects and we have no updates since December on this.
New IND for dCellVax was to be filed by end of March, so we have 3 more trading days for that to come out. The fact we have no update other than the S1 approval and divy shares of Regen whose value is completely dependent on good news coming in regards to either HemaXellerate I or dCellVax is becoming more of a concern each day. The large sell off this morning makes one wonder if those with inside information know that good news is not coming soon. The absence of good news or the presence of bad news will make both BMSN and Regen divvy shares worthless.
I've been banking that Koos would not go through the trouble of all the S1 filings and divvy registration unless he had solid data that either HemaXellerate experiments of dCellVax experiments were solid, but as time passes with no news, not even an update, my faith is wavering.
All IMHO
Something doesn't jive. The article you linked to states BMSN has a CEO named Michael D. West presenting in NY today:
In its latest news release, the company has announced that its Chief Executive Officer Micheal D West will represent the company at the Annual Regen Med Investor Day, on March 26, 2014 at New York.
Absolutely agree. Large amounts will not be invested in this company until FDA approval for either HemaXellerate or dCellVax is given, which is what we are waiting for. Large investors are about speculation, but not pure speculation which, given his past, is what we have currently with BMSN, though the facts of progress through filings and past PRs give us hope and indication that "pure speculation" is about to change in a big way. And when/if it happens, the trading of this stock and Regen will also change "in a big way".
There are many companies with FDA IND applications, but until they receive any kind of approval from the FDA, traders with enough clout to give enough fuel to the rise go nowhere near them due to the unpredictability of the share price.
I'm positive, BMSN is on many people's radars, but until that time they will not participate, all in my opinion.
Traz,
Can you sticky your response or sticky a response as to the expectation of deliver of Regen shares so that we don't have people asking the same question throughout the entire day.
thanks.
GM, thanks for the PM.
Thanks for the dates.
Thanks.
In the current case of BMSN, would that period extend to when Regen shares get final approval from FINRA?
The federal securities laws do not define the term "quiet period," which is also referred to as the "waiting period." However, a quiet period extends from the time a company files a registration statement with the SEC until SEC staff declare the registration statement "effective." During that period, the federal securities laws limit what information a company and related parties can release to the public. The failure to comply with these restrictions generally is referred to as “gun-jumping.”
Any theory as to when quiet period(s) would end?
Traz, GM, Popo, would Koos be under any mandated "quiet period" at this time concerning the upcoming initial public trading of Regen, and/or related to divy or end of quarter?
Trying to understand why no PR from company relating to Divy approval and other developments?
Certainly, it could be part of a strategy of holding to as late as possible all good news so as to bolster the public launch price of Regen shares and/or a private capital raising by selling x number of Regen shares to private investors in order to fund upcoming trials if they know already or are confident of FDA approval.
But are there any quiet periods attached to these developments when we cannot expect to see a company PR?
Thanks.
I'm thinking possible investor shares' offering of REGEN priced above $1 (say 10 million shares of Regen) in order to pay for all the initial clinical trials of HemaXellerate I.
What a wonderful "dilution" that would be to add 10 million Regen shares at $1 or over and suddenly BMSN and REGEN are a fully funded operation for the next year plus with possible 2 drugs going to phase I.
At that, the sceptics would be silenced and the "dilution machine" cry would end and the validation needed for larger investors would be in place.
THAT would be exciting for the long term!
IMO
Because of Regen shares divy and S1 approval with upcoming Regen ticker as initial publicly traded company, is Koos under any mandated "quiet periods" at this time.
With S1 approval and dividend approval, it seems strange to me that none of this good news has been released with a company PR.
Of course, theoretically, it could all be part of a strategy to only release news concerning FDA filings, approval, IND related to Regen controlled experiments as close as possible to opening trading of Regen to bolster price, especially since Regen cannot be shorted like BMSN and now that record date and ex-dividend? date are past, those with buckets of money can't scoop up Regen shares by buying the sub penny BMSN.
Any thoughts on this?
Why the silence from Koos even with all the good news that posters' D&D have shared with the rest of us?
Sorry, I don't know of a recommendation specifically for penny stocks.
Some answers are found if you look at a 3 month chart.
Show me a chart that goes up every day for even 2 weeks and chances are it is a false pump. Most stocks fluctuate. BMSN rocked from the .002s to .009 in 2 days and has been in a pull back ever since. Not shocking. Not surprising. Sure, I'd like to make a million dollars in a week, but doesn't happen.
Even at .005, BMSN is trading at twice was it was a short time ago and when the next piece of good news comes, it will go higher than .009 IMO.
Some DT, some Swing Trade, some sell on good news and some are holding for bigger returns bc we can't dedicate 7 hrs/day to watching the market and when news hits, it can jump 50% or more in 10 minutes in OTC.
Just have to pick and choose. No one knows the exact future of any stock on a minute by minute or day to day forecast. If they do, then it's a totally manipulated stock.
That's too bad. Drop in again when news comes out. Remember, the S1 filings clearly state HemaXellerate FDA response and dCellVax filings are expected by March 31st, so depends on one's vision, that's all.
Correct. We have PRs and S1/A filings, but we do not yet have confirmation that the Dividend will be issued, nor that Regen will be listed on any public stock exchange nor that HemaXellerate I will go to trials etc.
What we have is news and filings with the expectation that concrete news on all of the above is shortcoming.
For those who think all of the above is smoke screens and deception, the stock is overpriced and will collapse when bad news comes forth to confirm.
For those who believe the above is legitimate and part of the slow process any development company goes through over time and that PRs are not to be expected every 5 min or even every 5 days, then we believe the stock is grossly undervalued compared to where it will trade once one or more PRs confirm the approval of any of the above.
It's really quite simple and all the back and forth we have won't change the reality that is to come, good or bad.
Let's keep it real. I'm long bc I hope the news will be good on at least one of the above (Divy, HemaXellerate, dCellVax) which in my opinion will put the stock price over .01. If news is bad on all 3, I will lose, no doubt in my mind.
Popo, any idea how long BMSN and Regen have been listed as a client? Is this a new development?
Captain, you are right that many posts get too personal.
However, for those who've followed the D&D posted on this board for over a year and read the recent filings, including the S1 and amendments, it is no secret or new news that Koos has had to settle several litigations over the past couple years through the issuing of tons of shares of BMSN.
I agree that Koos and his history makes me nervous, but I'm invested bc there are also lots of facts regarding what HAS taken place over the past 2 years. Remember, Koos doesn't have to perform the experiments; he doesn't have to run the clinical trials and he doesn't have to manufacture the stem cells - all the scientific and important research, manufacturing and application is being done by contracted individuals and company. The scientists get rewarded only on success and success will pay for the trials etc.
So the past business problems are a fact and have value, but one should also consider: Filing of IND, experiments now done by MIN, the relationship with Benitec, the contract of MIN for his dCellVax, the news that the experiments for FDA response of HemaXellerate I are due in 2 weeks and the news that IND for dCellVax should be filed within next 2 weeks. BMSN has been a heavily shorted stock, but Regen will have less than 2% of the number of O/S as BMSN and therefore REGEN will not be open to the shorting of BMSN which in turn will raise the value of BMSN.
There is a lot HAPPENING, granted all in theory and on paper until the real news of approval can be given and that is the only real factor to me as to whether all this is and will be legit or whether it's all a fairy tale. I don't have the confidence in Koos, but I do get credit to MIN and others who are the ones the science and success of the experiments depend on.
All this is why I think the price of BMSN remains below .01 until one or more of the potential good news strikes. 1) DIVY Fully approved by FINRA and symbol issued for REGEN; 2) HemaXellerate I response is filed or 3)dCellVax IND is filed.
Any one of these may send BMSN over .01.
If none of these happens by March 31st, then BMSN will go back below .002 All IMO.
Not everyone here, and I hope most, is interested in pumping or bashing. But lots of the history of Koos and his failures has been documented and resolved. And who would resolve a litigation with shares of BMSN if they thought it was all a scam?
And the silent game of chicken continues...
Drum roll. VFIN AND VNDM pretty much sitting at the same level all day instead of lowering their prices and striving to drive down price. Interesting.
Seemingly large chunks blocking the road, but no panic selling and overall a fairly low day of volume. Will be interesting to see if OTC short report shows continuing decline of shorting that began 2 days back.
Frankly, considering the rapidity of the spike from .002 to .009, I'm surprised and happy it hasn't pulled back further, all of which lends to believe this upward move is real and not a flash in the pan caused by DTs.
In for long, for glory or bust. Stay tuned.
IMO
GLTA
Those waiting for a rocket will need to wait for a positive PR from Koos on either HemaXellerate I or dCellVax or Regen IPO verification.
Big money won't flow until confirmation of one of the above and then we will rocket. Time frame we've been given by company is before end of March, so time is ticking. Until then, it is cat and mouse IMHO.
Don't give yourself ulcers sitting 3 inches from the screen. Pull up a lazy chair if you've got your shares and wait for the big show to begin, hopefully within the next 2 weeks.
Love and Light, if the record date for dividend payout is March 18th, then how could one receive a dividend buying the stock next week after the 18th when they would not be the shareholder of the record date? Normally the ex-dividend date is before the record date. If someone owns 147 shares of BMSN on March 18th and sells them on the 20th to someone else, they both can't get dividend shares of Regen for the same 147 shares of BMSN. So either the record date is going to change or the ex-dividend date is going to be set retroactively it seems when this is approved. I don't see how both can be true.
"Great news everyone! I just got off the phone with TDAmeritrade Corporate Actions & Dividend Department... I wanted to get clarification if you can still BUY BMSN and get the Regen dividend up until the Ex-dividend date... AND YOU CAN!!! So expect the Ex-date to be designated by FINRA sometime in the next week to a month or so, but you can BUY BMSN up until then and receive the divi! WooHoo! So the rally shall continue! Best wishes everyone! smile"
Just want to put out a public thank you to those who have been posting real DD, analysis, and links to documents such as Popo, Traz and others.
I've never felt more calm about the great possibilities of BMSN and Regen future than right now. Nothing in market life is certain, but I sure feel better seeing that a real plan seems to be in place with the recent events of Divi filing, new Patent Application, and the fact that we can expect HemaXelerate I FDA response filing and dCellVax IND application all within the next 3 weeks.
The combination of those factors in line with all the documentation that was put together for the S1 filings gives me greater hope that the dCellVax IND will not meet the same time obstacles that HemaXellerate did. And the fact that BMSN will hold value in light of its ownership of Regen which won't have the massive float to short just adds to the light on the horizon.
I don't comment a lot but have been holding over a year with periods of real doubt. The way the price of BMSN has risen and held with the volume of shares traded adds to the hope of higher values ahead.
Pax
Thanks for the post of this article. Very encouraging.
Re: angelicsatan666 post# 113982
Post # of 114095
Read this..
http://m.us.wsj.com/articles/BL-VCDB-13997
Popo, this may be related to dCellVax treatment, but the application names Thomas Ichim as inventor whereas Min is the inventor of the dCellVax treatment and there is already patent for that that BMSN acquired if I recall correctly.
Patent Application refers back to Sep 2013 and even an earlier filing. As I recall, the HemaXellerate I patent from the hospital in Oregon? lapsed that BMSN had paid to license and after it lapsed, BMSN said that they would file to patent their process of developing and applying the technology, so I'm wondering is this patent is actually related to BMSN's HemaXellerate technology and application for which they have been preparing FDA response for clinical trials?
Which would be a PLUS as then both technologies would have some patent protection for the long haul and any derivation applications of the HemaXellerate II, III...
POPO - Patent granted or patent Application?
Thanks
VFIN raised bid to .0076.
No panic, let them keep raising the bid to cover.
If .08 goes, we rise quickly if we hold our shares close.
GLTA
Sure is nice to see the staying power throughout the day and what a great feeling awaiting the possibility of 2 major events in HemaXellerate I FDA response and dCellVax IND planned before end of month.
I'm guessing many major players are not going to enter the water until PR on positive news regarding either of those events which may really ignite this upward.
Can't recall a time recently where both BKMM and VFIN are bracketing the price, just trying to shake lose shares. Normally they are only on the sell side trying to drive it down as low as possible. The fact that their window is only .0005 between .0075 and .008 to be is very good indicator indeed.
GLTA I just need to hit .02 or .03 to make up the losses of the past 2 years. I'm all in.
VFIN and BKMM putting a ring around the market with 10,000 block bids at .0075 and block sells at .008
hmmm
Hopefully you can sell above that on positive news. Don't need to listen to chatter or rumors. The PR outline is for the end of this month, so we have 3 more weeks (or less) for the moment of truth to come out and the news, either good or bad, will send this stock quickly one direction or the other.
We know experiments are being conducted and last PR said it was encouraging. That isn't a guarantee of anything, but it is verification that things are being done and the time frame for those results is end of March for dCellVax and HemaXellerate.
The other main issue of dividend stock of Regen and approval has no time frame. We just know the last S1/A was filed shortly after the previous and hopefully is a good sign, but we can't know for certain.
Volume today and several days of upticks is an encouraging sign, especially if we stay above .0032 chartwise. I need to go above .006 unfortunately as I bought most of my shares above .01 on last year's run.
Ok, thanks.
Anyone have insights to CDEL?
CDEL has the big bid at .0033 and over the past week the biggest blocker to any run with large block sells.
Seems to be keeping a .0004 or .0005 range of blocks above and below. Can we trust the CDEL support at .0033?
If SEC approves S1 filing, will it be public right away or will we have to wait for PR from BMSN?
Yes, the one mistake I saw was a misspelling on one occasion of HemaXellerate as HemaXellaerate.
Whether or not that would disqualify a filing I will leave up to any expert on FDA filings. The misspelling is in a descriptive area and not a defining area, but I don't know how much that matters.
Certainly, if the filing response is: "The only mistake we found is one variation of the spelling of HemaXellerate as HemaXellaerate", then I would not think it will take very long to correct for approval.
Here's what we know objectively:
1. BMSN depends on Koos, no doubt.
2. Koos is now depending on Min for development of both dCellVax and HemaXellerate I experiments.
3. Company has released PR that timeframe is end of March for HemaXellerate FDA response filing and initial IND for dCellVax
4. In meantime, Koos has filed several S1/A stating the desire to do a stock dividend of 20,000,000 Regen shares to owners of BMSN.
5. Since Jan 29th filing of 2.9B shares, there has been no further dilution of shares.
6. Koos has been silent for a long period, either to remain in compliance with laws regarding S1 filings or as some would interpret personally, to deceive the world.
7. We haven't seen BKRT, VNDM or VFIN on the L2 sell for several days whereas previously, one or more were constantly there during the times that O/S were increased.
8. If Koos wants to make money off his reserved shares, he has to increase the value of BMSN and/or Regen.
Have I missed any basics?
In the end for FDA approval and clinical trials is the competence of those preparing the experiments asked by the FDA, i.e. Wei-Ping Min. I don't think you can discredit his competence and both the HemaXellerate approval and the dCellVax filings depend ultimately on the results of his experiments since the manufacturing side is already set up with an approved and experienced company and there is a legitimate doctor and hospital on board to conduct human trials.
The fact that Koos doesn't type well is a short term fix. If he wanted to "string this out", he would have waited a couple more weeks before filing another amendment.
Today's filing gives me a bit of relief that BMSN was not on an automatic monthly cycle of S1/A filings. I very good sign indeed although I still found HemaXellerate misspelled in the document once as HemaXellaerate. All misspellings of HemaXellarate had been corrected, but one combo HemaXellaerate is still there although it doesn't affect the understanding of the document. Don't know how picky FDA is on this, but certainly encouraging that today's filing was so quick after previous since it indicates someone was communicating with BMSN, and quickly for them to refile.
Disappointing. I'm beginning to wonder if the posts of PG about the possibility of Koos organizing the shorting might be true. After all, where does Koos get the money to lend to BMSN in return for shares when BMSN doesn't have the money to pay his salary?
Since I'm in over a year, I'll give this to the end of March and if by the end of March we don't see the filings for HemaXellerate I's responses to FDA and IND app for dCellVax, then I'm gone and unfortunately, will have to side with the fact that Koos' history hasn't changed.
Traz, can you or anyone else point out what is different or has changed in this new filing?
What is different and the impact? It still says in red towards the beginning that "this is incomplete and can be changed...".
So is every filing "incomplete" until the SEC approves or does that mean we should expect another filing?
Thanks.